NCT00185679终止2 期
A Feasibility Study Evaluating Haploidentical Allogeneic Transplantation Using the CliniMACS System in Patients With Advanced Hematologic Malignancies
Ginna Laport2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2001年11月最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 发起方
- 入组人数
- 13
- 试验地点
- 2
- 主要终点
- Neutrophil Engraftment
研究概览
简要总结
To assess the proportion of patients with donor neutrophil engraftment within 30 days of allogeneic transplant. To assess the incidence of acute GvHD during the first 100 days after transplantation.
详细描述
To assess the proportion of patients with donor neutrophil engraftment within 30 days of allogeneic transplant; assess the incidence of acute GvHD during the first 100 days after transplantation; and assess platelet engraftment, graft failure, chronic GvHD, clinical safety, and devise performance.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Neutrophil Engraftment
时间窗: 30 days post-transplant
Number of subjects recovering neutrophils, assessed as 1st of 3 consecutive days on which ANC \> 0.5x10e9/L
次要结局
- Acute GvHD (Grade II-IV)(within 100 days post-transplant)
- Platelet Recovery(40 days)
研究者
Ginna Laport
Associate Professor of Medicine
Stanford University
研究点 (2)
Loading locations...
相似试验
Unknown
2 期
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood TransplantationChronic Myeloid LeukemiaNon-Hodgkin LymphomaMyelodysplastic SyndromesAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaNCT00328237Colorado Blood Cancer Institute20
已完成
2 期
Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell TransplantationMultiple MyelomaNCT00461955University Hospital, Bordeaux13
已完成
不适用
NLCR in Prediction of the Grade of Lung Tumor.Lung NeoplasmNCT03749512Medical University of Silesia400
终止
2 期
Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched DonorsAcute Lymphoid Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)Non-Hodgkin LymphomaChronic Lymphocytic LeukemiaHodgkin LymphomaNCT03615105Memorial Sloan Kettering Cancer Center9
进行中（未招募）
2 期
MT2013-31: Allo HCT for Metabolic Disorders and Severe OsteopetrosisMucopolysaccharidosis DisordersHurler SyndromeHunter SyndromeMaroteaux Lamy SyndromeSly SyndromeAlpha-MannosidosisGlycoprotein Metabolic DisordersSphingolipidosesFucosidosisRecessive LeukodystrophiesGloboid Cell LeukodystrophyMetachromatic LeukodystrophyNiemann-Pick BNiemann-Pick C Subtype 2Sphingomyelin DeficiencyPeroxisomal DisordersAdrenoleukodystrophy With Cerebral InvolvementZellweger SyndromeNeonatal AdrenoleukodystrophyInfantile Refsum DiseaseAcyl-CoA Oxidase DeficiencyD-Bifunctional Enzyme DeficiencyMultifunctional Enzyme DeficiencyAlpha-methylacyl-CoA Racmase DeficiencyMitochondrial Neurogastrointestingal EncephalopathySevere OsteopetrosisHereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation)Inherited Metabolic DisordersAspartylglucosaminuriaNCT02171104Masonic Cancer Center, University of Minnesota149